Peter Ambrose Lander | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Peter Ambrose Lander is active.

Explore More

Publication

Featured researches published by Peter Ambrose Lander.

Bioorganic & Medicinal Chemistry Letters | 2015

Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists

Timothy Paul Burkholder; Brian Eugene Cunningham; Joshua Ryan Clayton; Peter Ambrose Lander; Matthew L. Brown; Robert Anthony Doti; Gregory L. Durst; Chahrzad Montrose-Rafizadeh; Constance King; Harold E. Osborne; Robert M. Amos; Richard W. Zink; Lawrence E. Stramm; Thomas P. Burris; Guemalli R. Cardona; Debra L. Konkol; Charles Reidy; Michael E. Christe; Michael James Genin

The design, synthesis, and structure activity relationships for a novel series of indoles as potent, selective, thyroid hormone receptor β (TRβ) agonists is described. Compounds with >50× binding selectivity for TRβ over TRα were generated and evaluation of compound 1c from this series in a model of dyslipidemia demonstrated positive effects on plasma lipid endpoints in vivo.

Archive | 2008

Compounds and methods for modulating fxr

Michael Gregory Bell; Robert Anthony Doti; Matthew Scott Dowling; Michael James Genin; Peter Ambrose Lander; Tianwei Ma; Nathan Bryan Mantlo; Jason Matthew Ochoada; Lindsay Scott Stelzer; Ryan Edward Stites; Alan M. Warshawsky

Bioorganic & Medicinal Chemistry Letters | 2005

Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).

Bryan H. Norman; Peter Ambrose Lander; Joseph Michael Gruber; Julian Stanley Kroin; Jeffrey Daniel Cohen; Louis Nickolaus Jungheim; James J. Starling; Kevin L. Law; Tracy D. Self; Linda B. Tabas; Daniel C. Williams; Donald C. Paul; Anne H. Dantzig

Bioorganic & Medicinal Chemistry Letters | 2005

3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists

David Andrew Neel; Matthew L. Brown; Peter Ambrose Lander; Timothy Alan Grese; Jean Marie Defauw; Robert Anthony Doti; Todd Fields; Sally Ann Kelley; Stephon C. Smith; Karen M. Zimmerman; Mitchell I. Steinberg; Prabhakar Kondaji Jadhav

Archive | 2003

Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators

Timothy Alan Grese; Prabhakar K. Jadhav; David Andrew Neel; Mitchell I. Steinberg; Peter Ambrose Lander

Archive | 2004

Indole-derivative modulators of steroid hormone nuclear receptors

Michael Gregory Bell; Konstantinos Gavardinas; Douglas Linn Gernert; Timothy Alan Grese; Prabhakar Kondaji Jadhav; Peter Ambrose Lander; Mitchell I. Steinberg

Archive | 2007

Compounds and Methods for Modulating Fx-Receptors

Michael Gregory Bell; Michael James Genin; Peter Ambrose Lander; Tianwei Ma; Lindsay Scott Stelzer; Robert Anthony Doti; Ryan Edward Stites; Francisco Javier Agejas-Chicharro; Melendo Ana Belen Bueno; Peter Rudolph Manninen; Jason Matthew Ochoada; Quanrong Shen; Alan M. Warshawsky

Archive | 2008

Compuestos derivados de [1,2,3]-tiazol-4-ilmetoxilo, agonista del receptor farnesoide x (fxr); composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dislipidemia y enfermedades relacionadas.

Michael Gregory Bell; Robert Anthony Doti; Matthew Scott Dowling; Michael J. Genin; Peter Ambrose Lander; Tianwei Ma; Natha

Archive | 2007

Composés et méthodes de modulation de fxr

Michael Gregory Bell; Robert Anthony Doti; Matthew Scott Dowling; Michael J. Genin; Peter Ambrose Lander; Tianwei Ma; Nathan Bryan Mantlo; Jason Matthew Ochoada; Lindsay Scott Stelzer; Ryan Edward Stites; Alan M. Warshawsky

Archive | 2007